HighCVENVD — high/critical CVEs (rolling 7d)· 21 Apr 2026

CVE-2026-21997 — Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Lif…

Severity: High · Kind: Vulnerability

Plain-English summary on the way

We've ingested this item but haven't summarised it yet. Read the upstream advisory using the link below in the meantime — the AI summary will appear here once the next run completes.

From the source

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Vulnerability facts

CVE: CVE-2026-21997
CVSS: 8.5

Read the original advisory →← All threat intel

Was this useful?

00000Sign in to react

Plain-English summaries are AI-generated and reviewed for tone, not technical accuracy. For incident response, always rely on the original source linked above.